Filana Therapeutics, Inc.(FLNA)

Biotechnology · Austin, TX

$0.84-0.03 (-3.71%)

Delayed quote: Oct 6, 2026, 12:30 PM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T16:32:19.321Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:32:19.321Z.

Quote observation: 2026-10-06T16:30:37.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -44,932,000
Quote market capitalization: 40,457,862
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 82,681,000

FMP input reference: 1e37222dd90dbab5e03bfa1bbf20eaf6e61690ec1e62f49524765e66f30de265

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

FLNA EBITDA Yield Metrics

EBITDA YIELD

N/A

FLNA Competitors' EBITDA Yield

FLNA

Filana Therapeutics, Inc.

Current

Market Cap

$40.46M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MGX

Metagenomi, Inc. Common Stock

vs FLNA

Market Cap

$40.28M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NEPH

Nephros, Inc.

vs FLNA

Market Cap

$39.96M

EBITDA Yield

4.88%

TTM Avg

3.36%

3Y Avg

3.05%

5Y Avg

3.05%

HBIO

Harvard Bioscience, Inc.

vs FLNA

Market Cap

$39.08M

EBITDA Yield

9.43%

TTM Avg

10.40%

3Y Avg

3.98%

5Y Avg

3.32%

PRPO

Precipio, Inc.

vs FLNA

Market Cap

$41.92M

EBITDA Yield

N/A

TTM Avg

0.46%

3Y Avg

0.46%

5Y Avg

0.46%

IXHL

Incannex Healthcare Limited

vs FLNA

Market Cap

$38.35M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BSEM

BioStem Technologies, Inc.

vs FLNA

Market Cap

$42.97M

EBITDA Yield

N/A

TTM Avg

14.45%

3Y Avg

11.70%

5Y Avg

11.70%

EDSA

Edesa Biotech, Inc.

vs FLNA

Market Cap

$37.33M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NNOX

Nano-X Imaging Ltd.

vs FLNA

Market Cap

$43.96M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELTX

Elicio Therapeutics, Inc.

vs FLNA

Market Cap

$36.61M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Filana Therapeutics, Inc. (FLNA)	$40.46M	N/A	N/A	N/A	N/A
Metagenomi, Inc. Common Stock (MGX)vs ›	$40.28M	N/A	N/A	N/A	N/A
Nephros, Inc. (NEPH)vs ›	$39.96M	4.88%	3.36%	3.05%	3.05%
Harvard Bioscience, Inc. (HBIO)vs ›	$39.08M	9.43%	10.40%	3.98%	3.32%
Precipio, Inc. (PRPO)vs ›	$41.92M	N/A	0.46%	0.46%	0.46%
Incannex Healthcare Limited (IXHL)vs ›	$38.35M	N/A	N/A	N/A	N/A
BioStem Technologies, Inc. (BSEM)vs ›	$42.97M	N/A	14.45%	11.70%	11.70%
Edesa Biotech, Inc. (EDSA)vs ›	$37.33M	N/A	N/A	N/A	N/A
Nano-X Imaging Ltd. (NNOX)vs ›	$43.96M	N/A	N/A	N/A	N/A
Elicio Therapeutics, Inc. (ELTX)vs ›	$36.61M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

FLNA EBITDA Yield Metrics

FLNA Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics